Legend Capital Joins China Renaissance To Lead $293M Investment In Chinese Diagnostics Medical Corporation

For Digital Subscribers Only

Chinese private equity firm Legend Capital has joined China Renaissance’s healthcare fund to co-lead an investment worth nearly RMB2 billion (US$293 million) in Chinese Diagnostics Medical Corporation.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

RELATED NEWS



LEAVE A REPLY